Navigation Links
Moles and melanoma -- researchers find genetic links to skin cancer

New research has shown why people with the greatest number of moles are at increased risk of the most dangerous form of skin cancer.

The study, led by Professors Julia Newton Bishop and Tim Bishop of the Melanoma Genetics Consortium (GenoMEL) at the University of Leeds, looked at more than 10,000 people, comparing those who have been diagnosed with melanoma to those who do not have the disease.

Researchers across Europe and in Australia, looked at 300,000 variations in their research subjects' genetic make-up, to pinpoint which genes were most significant in developing melanoma a disease which causes the overwhelming majority of skin cancer related deaths. Their findings are published in the journal Nature Genetics.

Across the large sample, a number of clear genetic patterns emerged.

It is already well known that red-haired people, those with fair skin and those who sunburn easily are most at risk of melanoma, and the people who had been diagnosed with melanoma were found to be much more likely to be carrying the genes most closely associated with red hair and freckles. "This is what we expected to find," said Professor Bishop of the Leeds Institute of Molecular Medicine and the Cancer Research UK Centre at Leeds. "But the links seemed to be much stronger than we anticipated."

"We had known for some time that people with many moles are at increased risk of melanoma. In this study we found a clear link between some genes on chromosomes 9 and 22 and increased risk of melanoma. These genes were not associated with skin colour," he added.

"Instead, in joint research with colleagues at King's College London and in Brisbane who counted the number of moles on volunteer twins, we showed that these genes actually influenced the number of moles a person has."

Around 48,000 people worldwide die of melanoma each year. It is more common in males and those with pale skin and is on the increase. It is widely believed that the increase in melanomas is largely due to social and behavioural activities, such as increased exposure to the sun, partly caused by the availability of cheaper foreign holidays. Sunny holidays increase the risk because it is intermittent sun exposure which causes melanoma rather than daily exposure over longer periods of time.

Even so, the process by which sunlight and genetics combine to cause cancer in some people, is still poorly understood, as Professor Bishop explained: "If you take the people who have the greatest exposure to sunlight those who work outside for example and compare them to those with the least exposure, their risks of getting skin cancer are actually quite similar. Statistically, the differences are quite negligible.

"What we do know is that the combination of particular genes and a lifestyle of significant sun exposure is putting people at greatest risk."

The research shows that there are at least five genes which influence the risk of melanoma. A person carrying all the variants associated with an increased risk is around eight times more likely to develop melanoma than those carrying none, though the majority of people carry at least one of these variants.

Sara Hiom, Cancer Research UK's director of health information, said: "The more we can understand malignant melanoma through research like this the closer we should get to controlling what is an often fatal cancer. This study confirms Cancer Research UK's advice in its SunSmart campaign that people with lots of moles as well as those with red hair and fair skin are more at risk of the most dangerous form of skin cancer and should take extra care in the sun.

"The research goes further and identifies the actual genes associated with this increased risk."


Contact: Simon Jenkins
University of Leeds

Related medicine news :

1. Melanomas may appear noticeably different than other moles
2. MWW Group Retained by MoleSafe
3. Study: Most female child molesters were victims of sexual abuse
4. MoleSafe USA Opens Second Location in Albuquerque, New Mexico
5. Melanoma Diagnosis Often Delayed for Rural Poor
6. Melanoma drug revs immune cells but cancer cells ignore it
7. Promising drug combination may help those with ocular melanoma that has spread
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
10. New type of drug shows promise in attacking melanoma in an innovative way
11. Genes Unlock New Treatments for Deadly Melanoma
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... The ... OSHA Training Institute Education Center headquartered in Northern California, has issued an important ... heat at their worksites. Employers with workers exposed to high temperatures should ...
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... for mental health professionals, announced today its affiliation with Tennessee Counseling Association. ... solutions to the network of the Tennessee Counseling Association, adding exclusive benefits and ...
(Date:6/27/2016)... ... June 27, 2016 , ... ePAY ... partnership with Connance, a healthcare industry leader providing predictive analytics to optimize ... combine to provide health systems, hospitals and ambulatory surgical centers with dramatic ...
(Date:6/27/2016)... ... 2016 , ... A revolution is underway. Brooklyn-based company, ... for the millions of people who require these medical transport services annually. ... the use of technology. Now, SmartEMS has put forth an industry-changing app that ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... DUBLIN , June 27, 2016 Jazz ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... proposed acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... 11:59 p.m. (Eastern Daylight Time). As previously ... entered into a definitive merger agreement under which Jazz ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology: